AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Board/Management Information May 3, 2022

4780_dirs_2022-05-03_6184d06b-1750-4c17-8ba8-c01111bed9d6.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1856K

Primary Health Properties PLC

03 May 2022

Primary Health Properties PLC

(the "Company" or "PHP")

Director appointment

Primary Health Properties PLC, a leading investor in modern primary healthcare facilities, announces, in accordance with Listing Rule 9.6.14(2), that Mr Richard Howell, Chief Financial Officer of the Company, has been appointed as a Non-executive Director of Life Science REIT plc (AIM: LABS), an externally managed real estate investment trust recently admitted to trading on the AIM market of the London Stock Exchange and focused on investing in a diversified portfolio of UK properties that are leased or intended to be leased to tenants operating in the life science sector.

ENDS

Further details:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 0797 3344768

Steven Owen

Chairman

Tel: +44 (0) 20 7451 7050

David Rydell / Steph Whitmore / Tilly Abraham

(Buchanan Communications)

Tel: +44 (0) 20 7466 5066

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNAJMFTMTJMBJT

Talk to a Data Expert

Have a question? We'll get back to you promptly.